Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rêveur Corporation appears to have been a California-licensed cannabis manufacturing, distribution, and transportation company operating within the broader Lifestyle Delivery Systems/Reveur Holdings structure. Public disclosures indicate that CSPA Group Inc. was acquired by Rêveur Holdings Inc. on October 1, 2018 and then renamed Rêveur Corporation. The business was associated with manufacturing cannabis products and supporting distribution operations in California, rather than running a conventional clinical-stage biotech pipeline. Historical materials from the parent group also referenced related psychedelic and cannabinoid intellectual property through affiliated subsidiaries, but identifiable drug-development assets were not clearly disclosed under Rêveur Corporation itself. Based on the available evidence, this was a commercial cannabis-health company/subsidiary rather than an independent, active biotech issuer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rêveur Corporation.